However; single nucleotide polymorphism (SNP) genotyping often remains dependent on arrays, leaving genotyping and NGS ...

The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...

Emboldened by the success of next-generation sequencing, scientists are pursuing the holy grail of genomics—the '$1,000 genome'—with single-molecule approaches. Nathan Blow reports.

“The potential expansion of clinical utility and the decreasing costs have brought next generation sequencing methods to the cusp of mainstream clinical diagnostic testing.” There are a host of policy ...

--Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate ...

SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

Next-generation size selection was assessed in an experimental benchmarking of 84 human genomic DNA samples from fresh blood for HiFi long-read sequencing library preparation.

Recently, the field has moved toward next-generation sequencing (NGS), which addresses limitations of current testing strategies, including cell culture and PCR assays.

About Singular Genomics Systems, Inc. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies.

SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers ...